Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cellspan Esophageal Implant (Harvard Apparatus Regenerative Technology)
- Development stage
- Unknown
- Lead developer
- Harvard Apparatus Regenerative Technology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Surgical Implantation
01
Overview
Cellspan Esophageal Implant (CEI) is a tissue-engineered regenerative medicine product developed by Biostage. It is a combination product consisting of autologous adipose-derived mesenchymal stromal cells (Ad-MSCs) seeded onto a proprietary biocompatible polyurethane tubular mesh scaffold. The implant is designed to act as a 'living tube' that, when surgically implanted, facilitates the regeneration of a functional esophageal neo-conduit by leveraging the body's inherent healing capacity. It is primarily targeted at treating pediatric and adult esophageal conditions, including esophageal atresia, cancer, and traumatic injury, where a segment of the esophagus is missing or severely damaged. The product has received Orphan Drug Designation from both the FDA and EMA for the treatment of esophageal atresia.
- Brand names
- Cellspan
- Other names
- Cellspan Esophageal ImplantCEI
Beyond the preview
Go deeper on Cellspan Esophageal Implant (Harvard Apparatus Regenerative Technology).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cellspan Esophageal Implant (Harvard Apparatus Regenerative Technology).